T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs

被引：55
作者：
Smith, JA
Bluestone, JA
机构：
来源：
CURRENT OPINION IN IMMUNOLOGY | 1997年 / 9卷 / 05期
关键词：
D O I：
10.1016/S0952-7915(97)80044-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Pc receptor nonbinding anti-CD3 monoclonal antibodies show promise for clinical application, in that they suppress graft rejection without the toxicity associated with conventional anti-CD3 antibody therapy. Recent studies suggest that the mechanism of soluble anti-CD3 antibody mediated immunosuppression involves partial signaling, induced cytokine deviation and Th1 cell inactivation.
引用
收藏
页码：648 / 654
页数：7
相关论文
共 39 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]  
ALEGRE ML, 1995, J IMMUNOL, V155, P1544
[3]  
ALEGRE ML, 1994, TRANSPLANTATION, V57, P1537
[4]   THE GENERATION OF A HUMANIZED, NON-MITOGENIC CD3 MONOCLONAL-ANTIBODY WHICH RETAINS INVITRO IMMUNOSUPPRESSIVE PROPERTIES [J].
BOLT, S ;
ROUTLEDGE, E ;
LLOYD, I ;
CHATENOUD, L ;
POPE, H ;
GORMAN, SD ;
CLARK, M ;
WALDMANN, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (02) :403-411
[5]   A THEORY OF SELF-NONSELF DISCRIMINATION [J].
BRETSCHER, P ;
COHN, M .
SCIENCE, 1970, 169 (3950) :1042-+
[6]   T cell antigen receptor signal transduction pathways [J].
Cantrell, D .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :259-274
[7]   EVIDENCE THAT ANTIHUMAN TUMOR-NECROSIS-FACTOR MONOCLONAL-ANTIBODY PREVENTS OKT3-INDUCED ACUTE SYNDROME [J].
CHARPENTIER, B ;
HIESSE, C ;
LANTZ, O ;
FERRAN, C ;
STEPHENS, S ;
OSHAUGNESSY, D ;
BODMER, M ;
BENOIT, G ;
BACH, JF ;
CHATENOUD, L .
TRANSPLANTATION, 1992, 54 (06) :997-1002
[8]  
Chatenoud L, 1997, J IMMUNOL, V158, P2947
[9]   TREATMENT OF ACUTE RENAL-ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL-ANTIBODY [J].
COSIMI, AB ;
BURTON, RC ;
COLVIN, RB ;
GOLDSTEIN, G ;
DELMONICO, FL ;
LAQUAGLIA, MP ;
TOLKOFFRUBIN, N ;
RUBIN, RH ;
HERRIN, JT ;
RUSSELL, PS .
TRANSPLANTATION, 1981, 32 (06) :535-540
[10]  
DEBETS JMH, 1990, J IMMUNOL, V144, P1304
1234